An experimental and molecular-modeling study of the binding of linked sulfated tetracyclitols to FGF-1 and FGF-2

被引:11
作者
Cochran, S [1 ]
Li, CP [1 ]
Bytheway, I [1 ]
机构
[1] Progen Ind Ltd, Drug Design Grp, Richlands BC, Qld 4077, Australia
关键词
angiogenesis; drug design; fibroblast growth factor; molecular modeling; surface plasmon resonance;
D O I
10.1002/cbic.200500089
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The experimental binding affinities of a series of linked sulfated tetracyclitols [Cyc(2)N-R-NCyc(2), where Cyc=C6H6(OSO3Na)(3) and R= (CH2)(n) (n=2-10), p-xylyl or (C2H4),-Ncyc] for the fibroblast growth factors FGF-1 and FGF-2 have been measured by using a surface plasmon resonance assay. The K, values range from 7.0 nM to 1.1 mu M for the alkyl-linked ligands. The binding affinity is independent of the flexibility of the linker, as replacement of the alkyl linker with a rigid p-xylyl group did not affect the K-D, Calculations suggest that binding modes for the p-xylyl-linked ligand are similar to those calculated for the flexible alkyl-linked tetracyclitols. The possible formation of cross-linked FGF:cyclitol complexes was examined by determining K-D values at increasing protein concentrations, No changes in K-D were observed; this suggesting that only 1:1 complexes are formed under these assay conditions. Monte. Carlo multiple-minima calculations of low-energy showed that all of the sulfated formers of the FGF-bound ligands showed tetracyclitol ligands. can bind effectively in the heparan. sulfate-binding sites of FGF-1, and FGF-2. Binding, affinities of these complexes were estimated by the Linear Interaction Energy (LIE) method to within a root-mean-square deviation of 1 kcal mol(-1) of the observed values. The effect of incorporating cations, to balance the overall charge of the complexes, during the, LIE calculations was also explored.
引用
收藏
页码:1882 / 1890
页数:9
相关论文
共 55 条
[1]   Binding affinity prediction with different force fields:: Examination of the linear interaction energy method [J].
Almlöf, M ;
Brandsdal, BO ;
Åqvist, J .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2004, 25 (10) :1242-1254
[2]   Ligand binding affinities from MD simulations [J].
Åqvist, J ;
Luzhkov, VB ;
Brandsdal, BO .
ACCOUNTS OF CHEMICAL RESEARCH, 2002, 35 (06) :358-365
[3]  
AQVIST J, 2001, FREE ENERGY CALCULAT, P171
[4]  
Banwell M. G., 2003, International Patent, Patent No. [WO03004454 A1, 03004454]
[5]   Structure-activity relationships of heparin-mimicking compounds in induction of bFGF release from extracellular matrix and inhibition of smooth muscle cell proliferation and heparanase activity [J].
Benezra, M ;
Ishai-Michaeli, R ;
Ben-Sasson, SA ;
Vlodavsky, I .
JOURNAL OF CELLULAR PHYSIOLOGY, 2002, 192 (03) :276-285
[6]   Poly(N-acryl amino acids):: A new class of biologically active polyanions [J].
Bentolila, A ;
Vlodavsky, I ;
Ishai-Michaeli, R ;
Kovalchuk, O ;
Haloun, C ;
Domb, AJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (13) :2591-2600
[7]   Lipase-catalyzed regioselective acylation of resorcin[4]arenes [J].
Botta, B ;
Zappia, G ;
Tafi, A ;
Botta, M ;
Manetti, F ;
Cernia, E ;
Milana, G ;
Palocci, C ;
Soro, S ;
Delle Monache, G .
JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC, 2002, 16 (5-6) :241-247
[8]   Molecular modeling as a powerful technique for understanding small-large molecules interactions [J].
Botta, M ;
Corelli, F ;
Manetti, F ;
Tafi, A .
FARMACO, 2002, 57 (02) :153-165
[9]   Validation of molecular docking calculations involving FGF-1 and FGF-2 [J].
Bytheway, I ;
Cochran, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (07) :1683-1693
[10]   Angiogenesis in health and disease [J].
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (06) :653-660